- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Advanced Magnetics, Inc. (Nasdaq: AMAG) today announced that it will participate in the Needham
& Company Biotech and Medical Conference being held June 14, 2007 at the New York Palace Hotel. Brian J.G. Pereira, MD, President and CEO of Advanced Magnetics, will present an overview of the company at 1:00 pm ET.
A live webcast of this presentation will be accessible through the Investors section of the company's website at http://www.advancedmagnetics.com . Following the conference, the webcast will be archived on the Advanced Magnetics website until July 13, 2007.
About Advanced Magnetics, Inc.
Advanced Magnetics, Inc. is a biopharmaceutical company that utilizes
its proprietary nanoparticle technology for the development and
commercialization of therapeutic iron compounds to treat anemia and novel
imaging agents to aid in the diagnosis of cancer and cardiovascular
Ferumoxytol, the company's key product candidate, is being developed
for use as an intravenous iron replacement therapeutic for the treatment of
iron deficiency anemia in chronic kidney disease. The company has completed
enrollment in four Phase III clinical trials with ferumoxytol and has
presented data on three of the four trials.
Combidex, the company's other product under development, is an
investigational functional molecular imaging agent consisting of iron oxide
nanoparticles for use in conjunction with magnetic resonance imaging (MRI)
to aid in the differentiation of cancerous from normal lymph nodes. In
March 2005, the company received an approvable letter from the FDA with
respect to Combidex, subject to certain conditions.
The company has two commercial products, Feridex I.V.(R) and
GastroMARK(R), both of which are imaging agents that are approved and
marketed in the United States, Europe and other countries.
For more information, please click here
Senior Director, Investor Relations
Copyright © PR Newswire Association LLC.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Researchers create a first frequency comb of time-bin entangled qubits: Discovery is a significant step toward multi-channel quantum communication and higher capacity quantum computers April 28th, 2016
Introducing the RE標ORK Bio-inspired Robotics Summit in Berlin April 27th, 2016